CellX Biosolutions AG

Novel bacterial solutions for industrial pollution treatment

Swiss Startup - CellX Biosolutions Main Image

CellX Biosolutions creates innovative bacteria-based products for efficient and targeted treatment of industrial chemical pollution. Pollution caused by industrial chemical by-products is a major global issue. Conventional disposal is costly and harmful, while current biological methods struggle at scale. We are creating high-performance bacterial products to effectively degrade hazardous industrial chemicals, leveraging a novel microfluidic-based tool to capture in remote environments bacteria capable of pollutant degradation.
The co-founding team is composed by Dr. Estelle Clerc (CEO), Geoffrey Besnier (COO) and Dr. Fabienne Kurt (CSO). Pollution treatment represents a 30 billion USD market, expected to increase by 82% by 2027.

Only registered users have access to funding information.
Please log in or register to continue. Registration is free.

11.09.2025

Das Finalisten-Feld des Swiss Technology Award 2025 (startupticker.ch)

08.09.2025

CellX Biosolutions: The Venture Leader Cleantech developing bacterial solutions for industrial pollution (venturelab.swiss)

28.08.2025

Venture Leaders Cleantech 2025 kick-off their Munich roadshow (venturelab.swiss)

19.08.2025

Ten high-potential cleantech startups selected for Munich investor roadshow (startupticker.ch)

19.08.2025

Swiss National Startup Team 2025: Ten high-potential Cleantech startups selected for Munich investor roadshow (venturelab.swiss)

06.08.2025

Ten cleantech startups selected for Climate Collider in the US (startupticker.ch)

19.06.2025

Life sciences, food and space start-ups sweep the prizes at the de Vigier award (startupticker.ch)

16.05.2025

Ten finalists proceed to W. A de Vigier finale (startupticker.ch)

16.05.2025

Eight Venture Kick alumni among finalists for De Vigier Award 2025 (venturekick.ch)

04.03.2025

15 Startups advance to next stage of the W.A. de Vigier Award (startupticker.ch)

25.02.2025

CellX secures CHF 1.7 million in pre-seed funding (startupticker.ch)

25.02.2025

CellX Biosolutions secures CHF 1.7M in Pre-Seed Funding to tackle PFAS degradation (venturekick.ch)

03.12.2024

3. Förderrunde von KlimUp: Vier Startups dabei (startupticker.ch)

27.05.2024

CHF 40,000 for safe treatments for hemophilia, cholestasis and liver disease, and for a sustainable treatment of industrial chemical waste (venturekick.ch)

No milestones

No Jobs

Videos

CellX Biosolutions by Venture Lab

TOP 100 Swiss Startup Award

The TOP 100 Swiss Startup Ranking features the 100 most promising startups that are not older than five years and are selected by a jury of early-stage investors.

TOP 100 Swiss Startups 2025

Website

Venture Kick

Venture Kick supports potential entrepreneurs with start capital up to CHF 150'000 as well as hands-on execution support and access to a nationwide network of investors and experts in the startup field. Multiple times per year, 8 selected projects get the opportunity to present their business ideas in front of a panel. The 5 most promising projects enter the support process. After 9 months at the latest, the startups incorporate and enter the market. Since 2007, Venture Kick has invested over CHF 58 million in over 1111 projects.

Venture Kick (150'000) 2024

Website